We sought to determine whether racial and socioeconomic disparities in the utilization of deep brain stimulation (DBS) for Parkinson's disease (PD) have improved over time. We examined DBS utilization and analyzed factors associated with placement of DBS. The odds of DBS placement increased across the study period, whereas White patients with PD were 5 times more likely than Black patients to undergo DBS. Individuals, regardless of racial background, with 2 or more comorbidities were 14 times less likely to undergo DBS. Privately insured patients were 1.6 times more likely to undergo DBS. Despite increasing DBS utilization, significant disparities persist in access to DBS. ANN NEUROL 2022;92:246-254.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546407PMC
http://dx.doi.org/10.1002/ana.26378DOI Listing

Publication Analysis

Top Keywords

undergo dbs
12
dbs
9
deep brain
8
brain stimulation
8
parkinson's disease
8
dbs utilization
8
patients times
8
times undergo
8
persistent racial
4
racial disparities
4

Similar Publications

Intermuscular coherence during co-contraction eliciting tasks as a biomarker for dystonia and GPi-DBS efficacy.

Clin Neurophysiol

December 2024

Department of Neurology, University Medical Center Groningen (UMCG), University of Groningen, Hanzeplein 1, 9700 RB Groningen, the Netherlands; Expertise Center Movement Disorders Groningen, University Medical Center Groningen (UMCG), the Netherlands. Electronic address:

Article Synopsis
  • Clinical rating scales often miss the full range of dystonic symptoms, prompting the need for a reliable biomarker to assess the effectiveness of deep brain stimulation (GPi-DBS) for treating dystonia.
  • In a study of 12 patients undergoing GPi-DBS, researchers found that those with arm dystonia had higher intermuscular coherence in the 4-12 Hz range before surgery, which significantly decreased after the procedure.
  • Despite the observed changes in coherence, the study found no strong links between coherence levels and clinical rating scale scores, suggesting that more research is needed to determine the biomarker's clinical utility.
View Article and Find Full Text PDF

Subthalamic (STN) deep brain stimulation (DBS) in Parkinson's disease (PD) patients not only improves kinematic parameters of movement but also modulates cognitive control in the motor and non-motor domain, especially in situations of high conflict. The objective of this study was to investigate the relationship between DBS-induced changes in functional connectivity at rest and modulation of response- and movement inhibition by STN-DBS in a visuomotor task involving high conflict. During DBS ON and OFF conditions, we conducted a visuomotor task in 14 PD patients who previously underwent resting-state functional MRI (rs-fMRI) acquisitions DBS ON and OFF as part of a different study.

View Article and Find Full Text PDF

: Depression is a known factor in poor cardiovascular outcomes but is often underassessed in cardiac units. This study evaluates the impact of depression on cardiovascular outcomes in patients undergoing cardiac interventions. The study included 133 patients who underwent uncomplicated procedures for degenerative aortic valve stenosis (n = 40), acute coronary syndrome (n = 29), or chronic coronary artery disease (n = 64).

View Article and Find Full Text PDF

The motor thalamus plays a crucial role in integrating and modulating sensorimotor information. Although voltage power spectral changes in the motor cortex with movement are well-characterized, corresponding activity in the motor thalamus, particularly broadband power change, remains unclear. The present study aims to characterize spectral changes in the motor thalamus during hand movements of 15 subjects undergoing awake deep brain stimulation surgery targeting the ventral intermediate (Vim) nucleus of the thalamus for disabling tremor.

View Article and Find Full Text PDF
Article Synopsis
  • The DBS-HITS study explores the effects of high-frequency deep brain stimulation (DBS) on patients with treatment-resistant schizophrenia, focusing on the ventral hippocampus (vHipp) which shows excessive activity affecting neurotransmitter balance.
  • This randomized controlled trial involves six patients who will alternately receive active DBS for three months and sham stimulation for the same duration, with subsequent personalized active stimulation following the crossover phase.
  • The study aims to evaluate the safety and efficacy of hippocampal DBS, its effects on clinical symptoms, neurocognition, and brain metabolism, and is the first of its kind in this field, registered under NCT05694000.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!